Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay | Scientific Reports
Clinical implications of BRAF mutation in thyroid carcinoma: Trends in Endocrinology & Metabolism
BRAF V600E-expressing cells upregulate senescence markers and show... | Download Scientific Diagram
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Figure 1 from Molecular Pathways Role of BRAF in Thyroid Oncogenesis | Semantic Scholar
BRAF antibody (20899-1-AP) | Proteintech
Frontiers | Diverse Mechanisms of BRAF Inhibitor Resistance in Melanoma Identified in Clinical and Preclinical Studies
BRAF Mutation and Its Importance in Colorectal Cancer | IntechOpen
Intermittent treatment of BRAFV600E melanoma cells delays resistance by adaptive resensitization to drug rechallenge | PNAS
The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer | Cancer Cell International | Full Text
BRAF Mutations in Hairy-Cell Leukemia | NEJM
How the BRAF V600E Mutation Defines a Distinct Subgroup of Colorectal Cancer: Molecular and Clinical Implications
Cancers | Free Full-Text | BRAF Mutation in Colorectal Cancers: From Prognostic Marker to Targetable Mutation
B-raf proto-oncogene (BRAF) protein structure. (A) Positions of typical... | Download Scientific Diagram
Melanomas with concurrent BRAF non-p.V600 and NF1 loss-of-function mutations are targetable by BRAF/MEK inhibitor combination therapy - ScienceDirect
Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches - ScienceDirect
Leveraging transcriptional dynamics to improve BRAF inhibitor responses in melanoma - eBioMedicine
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
BRAF Mutation in Patients with Stage III Melanoma | HCP
BRAF-mediated signaling in normal and cancer cells. In normal cells,... | Download Scientific Diagram
BRAF V600E and SRC mutations as molecular markers for predicting prognosis and conversion surgery in Stage IV colorectal cancer | Scientific Reports
BRAF V600E /PI3Ka H1047R Driven Tumors Display Widespread Heterogeneous... | Download Scientific Diagram
Adaptive feedback signaling in BRAF V600E-mutated mCRC. (A) In BRAF... | Download Scientific Diagram
Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches - ScienceDirect
Genes | Free Full-Text | Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks
Targeting BRAF V600E in metastatic colorectal cancer: where are we today? - ecancer
